160 Health International Limited (HKG:2656)
40.30
-0.60 (-1.47%)
At close: Oct 31, 2025
160 Health International Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 66.78 | 58.27 | 57.56 | 37.75 |
Cash & Short-Term Investments | 66.78 | 58.27 | 57.56 | 37.75 |
Cash Growth | 76.90% | 1.23% | 52.47% | - |
Accounts Receivable | 170.15 | 170.67 | 117.82 | 63.59 |
Other Receivables | 9.71 | 6.49 | 1.91 | 3.25 |
Receivables | 179.86 | 177.16 | 119.73 | 66.84 |
Inventory | 6.03 | 5.04 | 7.29 | 16.06 |
Prepaid Expenses | 17.48 | 13.43 | 10.69 | 10.59 |
Restricted Cash | 4.9 | 7.78 | 0.49 | 4.03 |
Other Current Assets | 13.1 | 11.91 | 10.03 | 20.89 |
Total Current Assets | 288.14 | 273.58 | 205.78 | 156.14 |
Property, Plant & Equipment | 12.41 | 20.93 | 27.11 | 19.4 |
Goodwill | - | 0.1 | 0.1 | 0.1 |
Other Intangible Assets | 1.6 | 1.74 | 2.23 | 2.7 |
Long-Term Deferred Tax Assets | 1.78 | 1.21 | 0.83 | - |
Other Long-Term Assets | 0.22 | 0.22 | 0.12 | 0.58 |
Total Assets | 304.15 | 297.77 | 236.17 | 178.92 |
Accounts Payable | 95.67 | 102.63 | 96.38 | 56.16 |
Accrued Expenses | 116.8 | 112.25 | 73.31 | 83.25 |
Current Portion of Long-Term Debt | 106.5 | 89.39 | 9.51 | 19.56 |
Current Portion of Leases | 7.8 | 7.12 | 5.65 | 8.25 |
Current Income Taxes Payable | - | 0.41 | 0.12 | - |
Current Unearned Revenue | 58.69 | 45.09 | 43.43 | 39.77 |
Other Current Liabilities | 9.76 | 14.37 | 24.86 | 337.12 |
Total Current Liabilities | 395.23 | 371.26 | 253.25 | 544.1 |
Long-Term Debt | 0.28 | 1.28 | 0.49 | 1.5 |
Long-Term Leases | 5.75 | 11.88 | 17.01 | 6.02 |
Long-Term Unearned Revenue | 1.09 | 1.86 | 5.97 | 19.73 |
Total Liabilities | 402.34 | 386.28 | 276.72 | 571.36 |
Common Stock | 0 | 0 | 0 | 58.19 |
Additional Paid-In Capital | 595.47 | 595.47 | 595.47 | 374.81 |
Retained Earnings | -983.53 | -964.42 | -856.73 | -747.92 |
Comprehensive Income & Other | 293.75 | 283.81 | 223.51 | -69.11 |
Total Common Equity | -94.31 | -85.14 | -37.75 | -384.02 |
Minority Interest | -3.88 | -3.37 | -2.81 | -8.41 |
Shareholders' Equity | -98.19 | -88.5 | -40.56 | -392.43 |
Total Liabilities & Equity | 304.15 | 297.77 | 236.17 | 178.92 |
Total Debt | 120.32 | 109.67 | 32.66 | 35.33 |
Net Cash (Debt) | -53.54 | -51.41 | 24.89 | 2.42 |
Net Cash Growth | - | - | 928.64% | - |
Net Cash Per Share | -0.18 | -0.17 | 0.09 | 0.01 |
Filing Date Shares Outstanding | 336.45 | 302.81 | 290.53 | 285.64 |
Total Common Shares Outstanding | 302.81 | 302.81 | 290.53 | 285.64 |
Working Capital | -107.09 | -97.67 | -47.47 | -387.96 |
Book Value Per Share | -0.31 | -0.28 | -0.13 | -1.34 |
Tangible Book Value | -95.91 | -86.97 | -40.07 | -386.82 |
Tangible Book Value Per Share | -0.32 | -0.29 | -0.14 | -1.35 |
Machinery | - | 17.34 | 17.46 | 16.76 |
Leasehold Improvements | - | 5.07 | 4.38 | 3.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.